Join us online for two half days of inspiring presentations, case studies and interactive panels with national and international pharmaceutical industry leaders.
We encourage all of our 2021 program participants to attend and take full advantage of this unique learning and networking experience, including taking part in dedicated collaborative group sessions.
Register
Invitations have been sent to all 2021 program participants. Be sure to check your inbox for your invitation to register. You can add this event to your calendar below.
Program
Our presenters include:
- Lorraine Chiroiu, CEO and Managing Director, AusBiotech
- Kathy Connell. Senior Director External Innovation Partnering (ANZ), Johnson & Johnson Innovation
- Jessica Droge. Executive Director of Business Development, Amgen
- Anand Gautam. Executive Director & Emerging Science Lead (Asia & Asia Pacific), Pfizer
- Dan Grant. CEO and Managing Director, MTPConnect
- Lyn Griffiths. Director, QUT Centre for Genomics and Personalised Health and the Bridge and BridgeTech Programs
- Elizabeth Kowaluk. Senior Director, Search & Evaluation, AbbVie
- Ed Lobenhofer. Director Nonclinical Safety Science, Amgen
- Sarah Meibusch. Principal, OneVentures
- Professor Trent Munro. Senior Group Leader, Australian Institute Bioengineering & Nanotechnology, UQ
- Brendan Nugent. Of Counsel, Spruson & Ferguson
- Siro Perez. Head of Life Sciences (ANZ), IP Group
- Garry Redlich. CEO and Managing Director, Implicit Bioscience
- Goslik Schepers. Senior Investment Manager, Queensland, Brandon Capital Partners.
Download the official 2021 Bridge Program Virtual Symposium Programme (PDF file)
Details:
| Location: | Zoom webinar |
| Start Date: | 21/10/2021 [add to calendar] |
| End Date: | 22/10/2021 |